Atrial fibrillation (AFib) can affect life expectancy due to factors that include age, underlying health conditions, race, and how this common cardiac arrhythmia—or abnormal heart rhythm— is treated.

Dr. Wellens: Transesophageal echo is important when you're not sure how long atrial fibrillation has been going on. It's also very important in the patient who has heart disease, because if there ...

When combined with atrial fibrillation (AF), it becomes even rarer ... Diamond Bar, CA, USA), intracardiac echocardiography (ICE), and x-ray, with no complications. Conclusion: This is the first ...

The Food and Drug Administration has granted traditional approval to Calquence with bendamustine and Rituxan for some ...

The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated ...

AI reveals hidden patterns in ECGs that human experts can't see, transforming a century-old clinical tool into a powerful ...

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...

The global electrophysiology market is forecasted to grow at a 7.6% CAGR, reaching USD 9.08 billion by 2034. The increasing ...

The FDA approved acalabrutinib in combination with bendamustine and rituximab for adults with previously untreated mantle ...